Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BIOA · against 334 other Healthcare companies of similar size
Ranked #175 of 335 · scores higher than 42% of peers
Bars: peers in each 10-point band of the valuation score41 peers with a valuation score of 30–39, including BIOA · Click a bar to see the companies
Mainly because of its earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | BIOA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 320 reported | -40.1% | -0.3% | 11% | 30% | |
| EBITDA yieldHigher is better · 341 reported | 472.2% | 2.0% | 99% | 50% | |
| Free cash flow yieldHigher is better · 173 reported | -32.2% | -9.2% | 19% | 20% | |
| Book yieldHigher is better · 326 reported | 137.4% | 52.2% | 87% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 175 | 205M USD | 33 | 36 | |
| 175 | 389M USD | 33 | 33 | |
| 175 | 186M USD | 33 | 43 | |
| 175 | 257M USD | 33 | 55 | |
| 175 | 274M USD | 33 | 57 | |
| 175 | 213M USD | 33 | ||
| 175 | 216M USD | 33 | 44 | |
| 175 | 285M USD | 33 | 38 | |
| 175 | 338M USD | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score